IMC 4.88% 8.6¢ immuron limited

News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...

  1. 190,344 Posts.
    lightbulb Created with Sketch. 2790

    March 5 (Reuters) - Immuron Ltd (IMC) :

    • SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PHASE 2 IMM-124E CLINICAL TRIAL TOP-LINE RESULTS

    (([email protected];))

 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.